Nationwide recall for thyroid drug

Major Rugby has issued a nationwide recall of 12 packages of its levothyroxine sodium tablets used to treat hypothyroidism, due to the medication being "subpotent" and delivering less than the prescribed dose. The affected products were distributed nationwide beginning in January 2025, and consumers are advised to return them to the point of purchase, although the company states that taking the medication is unlikely to cause adverse health effects. Customers should consult their healthcare provider if they have the recalled medication.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل